Standout Papers

CD24 signalling through macrophage Siglec-10 is a target for cancer immunothera... 2017 2026 2020 2023 900
  1. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy (2019)
    Amira Barkal, Rachel Brewer et al. Nature
  2. Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy (2017)
    Amira Barkal, Kipp Weiskopf et al. Nature Immunology

Immediate Impact

7 by Nobel laureates 12 from Science/Nature 58 standout
Sub-graph 1 of 21

Citing Papers

The hallmarks of cancer immune evasion
2024 Standout
Direct radical functionalization of native sugars
2024 StandoutNature
1 intermediate paper

Works of Maxim Markovic being referenced

CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
2019 StandoutNature
Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy
2017 Standout

Author Peers

Author Last Decade Papers Cites
Maxim Markovic 1106 537 467 7 1.5k
Layla J. Barkal 978 566 460 11 1.6k
Amira Barkal 1151 913 524 11 1.9k
Oliver Dorigo 853 592 548 13 1.4k
Jens Volkmer 842 376 351 9 1.4k
Megan K. Ruhland 738 442 559 10 1.3k
Jens Serneels 781 533 455 12 1.3k
Jason Hatakeyama 672 648 378 16 1.3k
Luigi P. Ruco 951 413 727 11 1.6k
Natalie Rittenhouse 1019 613 573 12 1.8k
Kevin Wei 845 462 976 5 1.7k

All Works

Loading papers...

Rankless by CCL
2026